A clinical trial of an investigational medication for the treatment of Tourette’s Disorder in children and adolescents.
Jerking. Squinting. Blinking. Sniffing.
And shaking their self-esteem.
Tourette’s disorder is a neurological disorder characterized by repetitive, involuntary movements and vocalizations called tics. Tics are either simple or complex. Simple motor tics are sudden, brief, repetitive movements such as eye blinking and other eye movements, facial grimacing, shoulder shrugging, and head or shoulder jerking. Simple vocalizations might include repetitive throat-clearing, sniffing, or grunting sounds. Complex tics are distinct, coordinated patterns of movements involving several muscle groups. Complex motor tics might include facial grimacing combined with a head twist and a shoulder shrug. Other complex motor tics may actually appear purposeful, including sniffing or touching objects, hopping, jumping, bending, or twisting.
IPS Research is seeking participants for a clinical trial of aripiprazole for the treatment of Tourette’s disorder in children and adolescents. If your 6 to 17 year old child has Tourette’s disorder, please consider our clinical research study for aripiprazole. Aripiprazole is currently approved by the FDA for the treatment of Tourette’s disorder in children, and this study will help us learn more about its long-term safety and effectiveness.
Qualified participants must meet the following requirements:
- Be 6 to 17 years of age
- Have had symptoms of Tourette’s disorder
- Does not have autism spectrum disorders, bipolar disorder, or schizophrenia
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel